- 1. (123-I)Sodium Iodide
- [A radiopharmaceutical containing the radioisotope I-123 with diagnostic property. After absorption, the iodide is distributed through the extracellular fluid of the body and accumulates in the thyroid gland, thereby allowing measurement of thyroid function. ( NCI )] (UMLS (NCI) C0304977) =Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical ;
=IODIDE (AS SODIUM IODIDE);
[DX202] NON-IMAGING AGENTS RADIOPHARMACEUTICALS =Sodium iodide I123 1 MIL;
Sodium iodide I123 0.2 MIL;
SODIUM IODIDE,I-123 100 MIC;
| - 51. 30im
- [Mandibular right first molar implant mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552201) =Medical Device =Artificial dentition;
|
- 2. (131-I)Sodium Iodide
- [A radiopharmaceutical containing the beta- and gamma-emitting radioisotope I-131. After absorption, the iodide is distributed through the extracellular fluid of the body and accumulates in the thyroid gland, thereby allowing the imaging of the thyroid. ( NCI )] (UMLS (NCI) C0304982) =Indicator, Reagent, or Diagnostic Aid; Inorganic Chemical ;
=IODIDE (AS SODIUM IODIDE);
[DX201] IMAGING AGENTS (IN VIVO) RADIOPHARMACEUTICALS =Sodium iodide I131 0.067 MIL/ML;
Sodium iodide I131 100 MIC;
Sodium iodide I131 15 MIL;
Sodium iodide I131 1 MIL;
Sodium iodide I131 2 MIL/ML;
Sodium iodide I131 50 MIL;
Sodium iodide I131 7.05 MIL;
SODIUM IODIDE,I-131 8-100 MIC | - 52. 31i
- [Mandibular right second molar implant ( HL7V3.0 )] (UMLS (HL7) C1552203) =Medical Device =Artificial dentition;
|
- 3. (2-Isothiocyanatoethyl)benzene
- [Phenethyl isothiocyanate. A naturally occurring compound found in some cruciferous vegetables. It is being studied as an agent to prevent cancer. ( NCI )] (UMLS (NCI) C0070558) =Organic Chemical; Pharmacologic Substance; Biologically Active Substance
| - 53. 31id
- [Mandibular right second molar implant distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552205) =Medical Device =Artificial dentition;
|
- 4. (6-Isothiocyanatohexyl)benzene
- (UMLS (NCI) C0099413) =Organic Chemical; Pharmacologic Substance ;
| - 54. 31im
- [Mandibular right second molar implant mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552204) =Medical Device =Artificial dentition;
|
- 5. 1 INT MAM-COR ART BYPASS
- [Direct myocardial revascularization in which the internal mammary artery is anastomosed to the right coronary artery, circumflex artery, or anterior descending coronary artery. The internal mammary artery is the most frequent choice, especially for a single graft, for coronary artery bypass surgery. ( MSH )] (UMLS (ICD9CM) C0021781) =Therapeutic or Preventive Procedure ;
| - 55. 32i
- [Mandibular right third molar implant ( HL7V3.0 )] (UMLS (HL7) C1552206) =Medical Device =Artificial dentition;
|
- 6. 1,3-Indandione, 2-(p-methoxyphenyl)-
- [A synthetic indanedione anticoagulant. Anisindione interferes with the vitamin K-dependent hepatic synthesis of active clotting factors by inhibiting the reduction of vitamin K. This leads to an inhibition of gamma-carboxylation of glutamic acid residues to gamma-carboxyglutamic acid in clotting factors II, VII, IX and X. The consequential effects of this inhibition include a reduced activity of these clotting factors and prolonged blood clotting time. ( NCI )] (UMLS (NCI) C0051919) =Organic Chemical; Pharmacologic Substance ;
=[BL100] ANTICOAGULANTS;
PHENINDIONE =ANISINDIONE 50 MG | - 56. 32id
- [Mandibular right third molar implant distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552208) =Medical Device =Artificial dentition;
|
- 7. 1-(Isopropylamino)-3-(4-(2-(cyclopropylmethoxy)ethyl)phenoxy)propan-2-ol Hydrochloride
- [The hydrochloride salt form of betaxolol, a beta-1-selective adrenergic receptor antagonist without intrinsic sympathomimetic activity. Betaxolol hydrochloride acts on the heart and circulatory system and decreases cardiac contractility and rate, thereby reducing cardiac output. When applied topically in the eye, it lowers intraocular pressure by reducing aqueous humor secretion. ( NCI )] (UMLS (NCI) C0543470) =Organic Chemical; Pharmacologic Substance =1-(4-(2-Cyclopropylmethoxy)ethyl)phenoxy)-3-))1-methylethyl)amino)-2-propanol;
=BETAXOLOL HYDROCHLORIDE 0.25 %;
BETAXOLOL HYDROCHLORIDE 0.5 %;
BETAXOLOL HYDROCHLORIDE 10 MG;
BETAXOLOL HYDROCHLORIDE 20 MG;
| - 57. 32im
- [Mandibular right third molar implant mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552207) =Medical Device =Artificial dentition;
|
- 8. 10i
- [Maxillary left lateral incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552174) =Medical Device =Artificial dentition;
| - 58. 3i
- [Maxillary right first molar implant ( HL7V3.0 )] (UMLS (HL7) C1552167) =Medical Device =Artificial dentition;
|
- 9. 111 In-B3
- [A radioimmunoconjugate of monoclonal antibody (MoAb) B3 labeled with Indium 111 (In-111). MoAb B3 is a murine MoAb that recognizes a Lewis Y carbohydrate antigen present on the surface of many carcinomas. This radioimmunoconjugate emits gamma radiation and X-Ray photons that can be captured by gamma camera allowing imaging of Lewis Y expressing tissues. ( NCI )] (UMLS (NCI) C0935762) In 111 Monoclonal Antibody B3;
Indium In 111 Monoclonal Antibody B3 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 59. 4,4'-[(4-Imino-2,5-cyclohexadien-1-ylidene)methylene]bisbenzenamine Monohydrochloride
- [A green, crystalline, solid dye that is one of the major components of magenta. Basic fuchsin is primarily used for bacterial identification, but is also used as a dye in textiles, leather, and printing inks. Exposure to basic fuchsin is irritating to the eyes and skin. The substance is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0073578) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Unclassified Ingredients;
Inactive Ingredient Preparations =BASIC FUCHSIN 0.3 GM;
BASIC FUCHSIN 0.53 %;
|
- 10. 111 Indium
- [A radioisotope with a physical half-life of 2.83 days, used to label agents for diagnosis, disease progression and treatment. (NCI) ( NCI )] (UMLS (NCI) C0303403) =Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope ;
=[DX201] IMAGING AGENTS (IN VIVO) RADIOPHARMACEUTICALS;
Unclassified Ingredients =INDIUM In 111 CAPROMAB PENDETIDE | - 60. 4-imino-1,3-diazabicyclo[3,1,0]-hexan-2-one
- (UMLS (NCI) C0097147) =Organic Chemical; Pharmacologic Substance ;
|
- 11. 11i
- [Maxillary left canine implant ( HL7V3.0 )] (UMLS (HL7) C1552175) =Medical Device =Artificial dentition;
| - 61. 4-Isoxazolecarboxamide, 5-Methyl-N-(4-(trifluoromethyl)phenyl)-
- [An anticancer drug that works by inhibiting a cancer cell growth factor. Also called SU101. ( NCI )] (UMLS (NCI) C0063041) =Organic Chemical; Pharmacologic Substance ;
=isoxazole;
[MS109] ANTIRHEUMATICS, OTHER =LEFLUNOMIDE 10 MG;
LEFLUNOMIDE 20 MG;
LEFLUNOMIDE 100 MG |
- 12. 125-Iodine
- [A radioactive isotope of iodine, a nonmetallic element of the halogen group. With a half-life of 60 days, iodine 125 occurs naturally and can be produced artificially. This agent has both therapeutic and diagnostic uses, particularly in thyroid disease. (NCI04) ( NCI )] (UMLS (NCI) C0796396) I-125;
I125 isotope;
Iodine 125;
Iodine I 125;
Iodine I-125;
IODINE,I-125;
IODINE,I-125 PREPARATION;
=Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope =I;
Inactive Ingredient Preparations =IODINE,I-125 0.01 MIC | - 62. 4i
- [Maxillary right second premolar implant ( HL7V3.0 )] (UMLS (HL7) C1552168) =Medical Device =Artificial dentition;
|
- 13. 12i
- [Maxillary left first premolar implant ( HL7V3.0 )] (UMLS (HL7) C1552176) =Medical Device =Artificial dentition;
| - 63. 5'-Inosinic Acid, Homopolymer Complex with 5'-Cytidylic Acid Homopolymer
- [interferon inducer consisting of a synthetic, mismatched double-stranded RNA; the polymer is made of one strand each of polyinosinic acid and polycytidylic acid. ( CSP )] (UMLS (NCI) C0032414) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =interferon inducer;
polynucleotide |
- 14. 131 I-MIBG
- [An I 131 radioiodinated synthetic analogue of the neurotransmitter norepinephrine. Meta-iodobenzylguanidine localizes to adrenergic tissue and, in radioiodinated forms, may be used to image or eradicate tumor cells that take up and metabolize norepinephrine. ( NCI )] (UMLS (NCI) C0879568) I 131 Metaiodobenzylguanidine;
I 131 Meta-iodobenzylguanidine;
Iodine I 131 Metaiodobenzylguanidine;
=Organic Chemical; Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid | - 64. 5-Iodo-2-pyrimidinone-2'-deoxyribose
- [An oral prodrug of 5-iododeoxyuridine (IUdR), an iodinated analogue of deoxyuridine and radiosensitizing agent. 5-Iodo-2-pyrimidinone-2-deoxyribose (IPdR) is efficiently converted to IUdR by a hepatic aldehyde oxidase. This results in increased IUdR plasma levels compared to oral IPdR and increased toxicity profile compared to intravenous administered IUdR. IUdR is incorporated into DNA during the S-phase of the cell cycle, thereby sensitizing cells to ionizing radiation by increasing DNA strand breaks. ( NCI )] (UMLS (NCI) C0088688) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance
|
- 15. 131-I-Anti-B1 Monoclonal Antibody
- [A monoclonal antibody directed against a protein (CD20) expressed on the surface of B-lymphocytes and radiolabeled with the radioisotope I 131 with potential antineoplastic activity. Iodine 131 tositumomab delivers radiation selectively to neoplastic CD20-expressing B-lymphocytes cells, thereby decreasing the risk of systemic radiotoxicity. ( NCI )] (UMLS (NCI) C0768182) I 131 Bexxar;
I 131 Monoclonal Antibody Anti-B1;
I 131 Tositumomab;
I131-MOAB-B1;
Iodine I 131 MOAB Anti-B1;
Iodine I 131 Monoclonal Antibody Anti-B1;
Iodine I 131 Tositumomab;
Iodine-131 Anti-B1 Antibody;
Iodine-131 Anti-CD20 Monoclonal Antibody;
Iodine-131 Tositumomab;
TOSITUMOMAB IODINE-131;
TOSITUMOMAB IODINE-131 PREPARATION =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor =anti-B1;
Unclassified Ingredients =TOSITUMOMAB IODINE-131 0.61 MCI/ML;
TOSITUMOMAB IODINE-131 VIAL 5.6MCI/ML | - 65. 5-isoandrosterone
- [A 17-ketosteroid which excreted in the urine as a metabolite of steroid hormones. The most common form of etiocholanolone present in the urine is the sulfate salt. This agent, also known as 5-isoandrosterone, may be used to evaluate adrenal cortex function, bone marrow performance and, in neoplastic disease, for immunostimulation. (NCI04) ( NCI )] (UMLS (NCI) C0015124) =Steroid; Hormone ;
|
- 16. 131-Iodine
- [A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production. ( NCI )] (UMLS (NCI) C0303029) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope
| - 66. 5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,(1S)-, ethanedioate(1:1)
- [The oxalate salt of escitalopram, a pure S-enantiomer of the racemic bicyclic phthalane derivative citalopram, with antidepressant activity. As a selective serotonin reuptake inhibitor (SSRI), escitalopram blocks the reuptake of serotonin by neurons in the central nervous system (CNS), thereby potentiating CNS serotonergic activity. ( NCI )] (UMLS (NCI) C1170746) Escitalopram Oxalate;
ESCITALOPRAM OXALATE UNIDENTIFIED;
ESCITALOPRAM OXALATE PREPARATION;
ESCITALOPRAM OXALATE UNIDENTIFIED =Organic Chemical; Pharmacologic Substance =ESCITALOPRAM;
Unclassified Ingredients =Escitalopram 10 MG Oral Tablet;
Escitalopram 5 MG Oral Tablet;
Escitalopram 20 MG Oral Tablet;
Escitalopram 1 MG/ML Oral Solution |
- 17. 131I-HuCC49-deltaCH2
- [A radioimmunoconjugate consisting of the humanized monoclonal antibody (MoAb) CC49 having CH2 domain deleted, labeled with iodine 131 (I-131). MoAb CC49-deltaCH2 recognizes an epitope of the tumor-associated glycoprotein (TAG) 72 that is expressed by a wide range of cancers, including colorectal, gastric, pancreatic, ovarian, endometrial, breast, non-small cell lung, and prostate cancers. I-131 MoAb CC49-delta CH2 delivers beta and gamma radiation emitting I-131 nuclide directly to tumor cells that express TAG-72, thereby allowing imaging and/or treatment of cancers. ( NCI )] (UMLS (NCI) C1134477) 131I-MOAB CC49-deltaCH2;
I131 MOAB CC49-deltaCH2;
Iodine I 131 Monoclonal Antibody CC49-deltaCH2 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 67. 5i
- [Maxillary right first premolar implant ( HL7V3.0 )] (UMLS (HL7) C1552169) =Medical Device =Artificial dentition;
|
- 18. 131I-mAbF19
- [A radioimmunoconjugate of a murine monoclonal antibody (MoAb) F19 labelled with Iodine 131 (I-131). MoAb F19 was raised against fibroblast activation protein (FAP), which is highly expressed by tumor stromal cells. Using MoAb F19 as a carrier for I-131 results in the targeted imaging and/or destruction of cells overexpressed FAP. ( NCI )] (UMLS (NCI) C0796525) I 131 Monoclonal Antibody F19;
Iodine I 131 Monoclonal Antibody F19;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor | - 68. 6i
- [Maxillary right canine implant ( HL7V3.0 )] (UMLS (HL7) C1552170) =Medical Device =Artificial dentition;
|
- 19. 13i
- [Maxillary left second premolar implant ( HL7V3.0 )] (UMLS (HL7) C1552177) =Medical Device =Artificial dentition;
| - 69. 7i
- [Maxillary right lateral incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552171) =Medical Device =Artificial dentition;
|
- 20. 14i
- [Maxillary left first molar implant ( HL7V3.0 )] (UMLS (HL7) C1552178) =Medical Device =Artificial dentition;
| - 70. 8i
- [Maxillary right central incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552172) =Medical Device =Artificial dentition;
|
- 21. 15i
- [Maxillary left second molar implant ( HL7V3.0 )] (UMLS (HL7) C1552179) =Medical Device =Artificial dentition;
| - 71. 9i
- [Maxillary left central incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552173) =Medical Device =Artificial dentition;
|
- 22. 16i
- [Maxillary left third molar implant ( HL7V3.0 )] (UMLS (HL7) C1552180) =Medical Device =Artificial dentition;
| - 72. I
- [Maxillary left first primary molar ( HL7V3.0 )] (UMLS (HL7) C0227093) =Body Part, Organ, or Organ Component =Primary dentition;
|
- 23. 17i
- [Mandibular left third molar implant ( HL7V3.0 )] (UMLS (HL7) C1552181) =Medical Device =Artificial dentition;
| - 73. I
- [nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90; it is a nutritionally essential element and is especially important in thyroid hormone synthesis; in solution, it has anti-infective properties and is used topically. ( CSP )] (UMLS (NCI) C0021968) =Pharmacologic Substance; Biologically Active Substance; Element, Ion, or Isotope =halogen;
Micronutrient;
[DE101] ANTIBACTERIAL, TOPICAL;
[DX101] NON-IONIC CONTRAST MEDIA;
[PH000] PHARMACEUTICAL AIDS / REAGENTS;
=125-Iodine;
IODINE (AS POTASSIUM);
DIATR More… |
- 24. 17id
- [Mandibular left third molar implant distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552183) =Medical Device =Artificial dentition;
| - 74. I & D PALMAR/THENAR SPAC
- [ ] (UMLS (ICD9CM) C0177579) =Therapeutic or Preventive Procedure
|
- 25. 17im
- [Mandibular left third molar implant mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552182) =Medical Device =Artificial dentition;
| - 75. I 123 Monoclonal Antibody 81C6
- [A radioimmunoconjugate of a IgG2 monoclonal antibody (MoAb) 81C6 labeled with iodine 123 (I-123). MoAb 81C6 recognizes the extracellular matrix antigen tenascin (hexabrachion), which is up-regulated in gliomas and other cancers. Using MoAb 81C6 as a carrier for I-123 allows detection of tumor localization and distribution of MoAb 81C6 in diagnostic imaging procedures. ( NCI )] (UMLS (NCI) C0796330) iodine I 123 MOAB 81C6;
Iodine I 123 Monoclonal Antibody 81C6 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 26. 18i
- [Mandibular left second molar implant ( HL7V3.0 )] (UMLS (HL7) C1552184) =Medical Device =Artificial dentition;
| - 76. I 124 Monoclonal Antibody A33
- [A radioimmunoconjugate of a humanized monoclonal antibody (MoAb) A33 labelled with Iodine 124 (I-124). MoAb A33 recognizes A33 antigen, a 43 KDa transmembrane glycoprotein of the immunoglobulin superfamily, highly and homogenously expressed in 95% of colorectal cancer metastases, with only restricted expression in normal colonic mucosa. I-124 MoAb A33 delivers beta particle emitting I-124 nuclide directly to metastatic colorectal tissues, thereby could be used in kinetics studies or radioimmunotherapy. ( NCI )] (UMLS (NCI) C0677678) =Amino Acid, Peptide, or Protein; Immunologic Factor; Indicator, Reagent, or Diagnostic Aid
|
- 27. 18id
- [Mandibular left second molar implant distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552186) =Medical Device =Artificial dentition;
| - 77. I 131 Antiferritin Immunoglobulin
- [A radioimmunoconjugate of a rabbit antihuman ferritin IgG labeled with iodine 131 (I-131). Using anti-ferritin IgG as a carrier for I-131 may result in the targeted imaging and/or destruction of cells expressing ferritin. Observed in 35% to 100% of patients with hepatocellular carcinoma, high serum ferritin levels may be due to ferritin production by the tumor cells, or related to the associated iron overload and/or cirrhosis. ( NCI )] (UMLS (NCI) C0280029) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 28. 18im
- [Mandibular left second molar implant mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552185) =Medical Device =Artificial dentition;
| - 78. I 131 Liothyronine
- [A radioconjugate of synthetic active thyroid hormone, liothyronine (T3), labeled with Iodine 131. Liothyronine involves many important metabolism and is essential to proper development and differentiation of all cells. I131 liothyronine may be used in radiotherapy in thyroid cancers. ( NCI )] (UMLS (NCI) C0338103) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
|
- 29. 19i
- [Mandibular left first molar implant ( HL7V3.0 )] (UMLS (HL7) C1552187) =Medical Device =Artificial dentition;
| - 79. I 131 MOAB BC8
- [A radioimmunoconjugate consisting of BC8, a murine IgG1 anti-CD45 monoclonal antibody labeled with iodine 131 (I-131), with radioimmunotherapeutic properties. Using monoclonal antibody BC8 as a carrier for I-131 results in the targeted destruction of cells expressing CD45. CD45 is tyrosine phosphatase expressed on virtually all leukocytes, including myeloid and lymphoid precursors in bone marrow and mature lymphocytes in lymph nodes; it is also expressed on most myeloid and lymphoid leukemic cells, but not on mature erythrocytes or platelets. (NCI04) ( NCI )] (UMLS (NCI) C0796627) I 131 Monoclonal Antibody BC8;
iodine I 131 MOAB BC8;
Iodine I 131 Monoclonal Antibody BC8;
MOAB BC8, iodine I 131;
monoclonal antibody BC8, iodine I 131 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 30. 19id
- [Mandibular left first molar implant distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552189) =Medical Device =Artificial dentition;
| - 80. I 131 MOAB TNT-1/B
- [An iodine 131 labeled radioimmunoconjugate of monoclonal antibody (MOAB) TNT-1/B with radioimaging and antineoplastic properties. MOAB TNT-1/B was developed for radioimmunotherapy of solid tumors, designated as Tumor Necrosis Treatment (TNT). TNT exploits the presence of degenerating and necrotic cells within tumors by utilizing MOAbs directed against universal, intracellular nucleosomal determinants consisting of histone H1 and DNA. This MOAB was conjugated with biotin (B) molecules, which increase pharmacokinetic performance of the monoclonal antibody. MOAB TNT-1/B delivers I 131 to tumor cells and results in the targeted imaging and/or destruction of cells with exposed necrotic antigens. ( NCI )] (UMLS (NCI) C0879273) I 131 Monoclonal Antibody TNT-1/B;
iodine I 131 MOAB TNT-1/B;
Iodine I 131 Monoclonal Antibody TNT-1/B =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 31. 19im
- [Mandibular left first molar implant mesial hemisection ( HL7V3.0 )] (UMLS (HL7) C1552188) =Medical Device =Artificial dentition;
| - 81. I 131 Monoclonal Antibody 3F8
- [A radioimmunoconjugate consisting of 3F8, a murine anti-GD2 ganglioside monoclonal antibody labeled with iodine 131 (I-131), with radioimaging and radioimmunotherapeutic properties. Using monoclonal antibody 3F8 as a carrier for I-131 results in the targeted imaging and/or destruction of cells expressing GD2. GD2 is a ganglioside which is overexpressed in malignant melanoma, neuroblastoma, and small cell carcinoma of the lung. (NCI04) ( NCI )] (UMLS (NCI) C0393072) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 32. 1i
- [Maxillary right third molar implant ( HL7V3.0 )] (UMLS (HL7) C1552165) =Medical Device =Artificial dentition;
| - 82. I 131 Monoclonal Antibody 81C6
- [A radioimmunoconjugate of a human-murine chimeric IgG2 monoclonal antibody (MoAb) 81C6 labeled with iodine 131 (I-131), with imaging and radioimmunotherapeutic properties. MoAb 81C6 recognizes the extracellular matrix antigen tenascin (hexabrachion), up-regulated in gliomas and other cancers. Using MoAb 81C6 as a carrier for I-131 results in the targeted imaging and/or destruction of cells expressing tenascin. ( NCI )] (UMLS (NCI) C0796329) iodine I 131 MOAB 81C6;
Iodine I 131 Monoclonal Antibody 81C6 =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor |
- 33. 2 INT MAM-COR ART BYPASS
- [ ] (UMLS (ICD9CM) C0190242) =Therapeutic or Preventive Procedure
| - 83. I 131 Monoclonal Antibody A33
- [A radioimmunoconjugate of a humanized monoclonal antibody (MoAb) A33 labelled with Iodine 131 (I-131). MoAb A33 recognizes A33 antigen, a 43 KDa transmembrane glycoprotein of the immunoglobulin superfamily, highly and homogenously expressed in 95% of colorectal cancers, with only restricted expression in normal colonic mucosa. Using MoAb A33 as a carrier for I-131 results in the targeted imaging and/or destruction of cells expressed A33 antigen. ( NCI )] (UMLS (NCI) C0678093) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 34. 2,4-Imidazolidinedione, 5,5-diphenyl-3-((phosphonooxy)methyl)-, Disodium Salt
- [The sodium salt form of fosphenytoin, a prodrug that is hydrolyzed to the anticonvulsant phenytoin upon parental administration. Phenytoin exerts its effect most likely through an enhancement of sodium efflux from neurons in the motor cortex. This leads to a suppression of excessive neuronal firing and spread of seizure activity. Other physiologic effects from actions of phenytoin include modulation of the voltage-dependent calcium channels of neurons, inhibition of calcium flux across neuronal membranes and enhancement of sodium-potassium ATPase activity of neurons and glial cells. (NCI05) ( NCI )] (UMLS (NCI) C0284906) =Organic Chemical; Pharmacologic Substance =Fosphenytoin;
=FOSPHENYTOIN SODIUM 50 MG-PE/ML | - 84. I 131 Monoclonal Antibody CC49
- [A radioimmunoconjugate of the humanized monoclonal antibody (MoAB) CC49 labeled with iodine 131 (I-131). MoAb CC49 recognizes the pancarcinoma tumor-associated glycoprotein (TAG)-72 with high affinity. I-131 MoAb CC49 delivers beta and gamma radiation emitting I-131 nuclide directly to tumor cells that express TAG-72, thereby allowing imaging and/or treatment of cancers. ( NCI )] (UMLS (NCI) C1327845) Iodine I 131 Monoclonal Antibody CC49;
=Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
|
- 35. 2-Imino-4-keto-5-phenyltetrahydrooxazole
- [An oxazolidine compound with central nervous system (CNS) stimulant property. Although pemoline has pharmacological activity similar to other CNS stimulants, the exact mechanism and site of action are unknown. This agent has minimal sympathomimetic properties, but animal studies indicate it may work through dopaminergic mechanisms. Pemoline has been withdrawn from the U.S. market because of the agent's association with life threatening hepatic failure. ( NCI )] (UMLS (NCI) C0030800) =Organic Chemical; Pharmacologic Substance =oxazole;
[CN809] CNS STIMULANTS, OTHER =PEMOLINE 37.5 MG;
PEMOLINE 75 MG;
PEMOLINE 18.75 MG;
| - 85. I 131 Monoclonal Antibody G-250
- [A radioimmunoconjugate comprised of the chimeric monoclonal antibody G-250 conjugated with iodine I 131 with potential antineoplastic activity. The antibody moiety of iodine I 131 chimeric monoclonal antibody G-250 binds to G-250, a renal-cell carcinoma-associated antigen, delivering cytotoxic iodine I 131 specifically to renal carcinoma cells that express G-250. ( NCI )] (UMLS (NCI) C0677789) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
|
- 36. 2-Isopropylaminopyrimidine
- (UMLS (NCI) C0063890) =Organic Chemical; Pharmacologic Substance ;
| - 86. I 131 Monoclonal Antibody Lym-1
- [A radioimmunoconjugate of a murine monoclonal antibody, MoAb Lym-1, labeled with iodine 131 (I-131). MoAb Lym-1 recognizes an epitope of the histocompatibility antigen HLA-DR, which is over-expressed on most B-cell lymphomas. I-131 MoAb Lym-1 delivers beta and gamma radiation emitting I-131 nuclide directly to tumor cells that express HLA-DR, thereby allowing imaging and/or treatment of cancers. ( NCI )] (UMLS (NCI) C1134561) Iodine I 131 Monoclonal Antibody Lym-1 =Pharmacologic Substance; Immunologic Factor
|
- 37. 20i
- [Mandibular left second premolar implant ( HL7V3.0 )] (UMLS (HL7) C1552190) =Medical Device =Artificial dentition;
| - 87. I 131 Uptake
- [A type of nuclear test of the thyroid that measures how much radioactive iodine is taken up by the thyroid gland in a given time period. This test is performed to evaluate thyroid function, particularly when blood tests of thyroid function (for example, T3 or T4 levels) have abnormal results. (from Medline Plus Medical Encyclopedia) ( NCI )] (UMLS (NCI) C0203778) =Diagnostic Procedure
|
- 38. 21i
- [Mandibular left first premolar implant ( HL7V3.0 )] (UMLS (HL7) C1552191) =Medical Device =Artificial dentition;
| - 88. I cell disease
- [rapidly progressing disease of young children, characterized histologically by abnormal fibroblasts containing a large number of dark inclusions which fill the central part of the cytoplasm except for the juxtanuclear zone (I cells), and clinically by severe growth impairment, minimal hepatomegaly, extreme mental and motor retardation, and clear corneas; inherited as an autosomal recessive trait, it is caused by failure of lysosomal enzymes to be incorporated into lysosomes. ( CSP )] (UMLS (CSP) C0020725) =Disease or Syndrome =inborn lipid storage disorder;
inborn lysosomal enzyme disorder |
- 39. 22i
- [Mandibular left canine implant ( HL7V3.0 )] (UMLS (HL7) C1552192) =Medical Device =Artificial dentition;
| - 89. I Kappa B
- [Interacting with p65 (RELA), widely expressed 36-38kDa unphosphorylated cytoplasmic ANK-repeat human I Kappa B Proteins A/B/E (NFKBI Family) inhibit NF-Kappa-B, trapping it in the cytoplasm. By complexing with NFKB, IKBs regulate NFKB transcription in cell adhesion, immune and proinflammatory responses, apoptosis, differentiation, and growth. Cytokine-activated serine phosphorylation of IKBs by IKBKA/IKBKB disables the NFKB inhibition by dissociation; promotes polyubiquitinated proteasome-dependent IKB degradation; and allows NFKB nuclear translocation, binding at kappa-B DNA motifs, and target gene transcription. (NCI) ( NCI )] (UMLS (NCI) C0167954) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
|
- 40. 23i
- [Mandibular left lateral incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552193) =Medical Device =Artificial dentition;
| - 90. I Kappa B A
- [One of a number of ankyrin-rich proteins known as IkappaB that interact with and regulate members of the Rel/NF-kappaB family of transcription factors. IkappaB-alpha is the inhibitory subunit of NF-kappaB. ( NCI )] (UMLS (NCI) C0126732) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 41. 24i
- [Mandibular left central incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552194) =Medical Device =Artificial dentition;
| - 91. I kappa B beta
- [ubiquitous inducible nuclear transcription factor that binds enhancer elements in many different cell types; is activated by pathogenic stimuli. ( CSP )] (UMLS (CSP) C0166033) =Amino Acid, Peptide, or Protein; Biologically Active Substance =transcription factor;
|
- 42. 25i
- [Mandibular right central incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552195) =Medical Device =Artificial dentition;
| - 92. I-123
- [A radioactive isotope of iodine, a nonmetallic element of the halogen group, with an atomic mass of 123 and a half-life of 13.2 hours with radioimaging property. Selectively accumulating in thyroid glands, iodine I 123 emits gamma rays that can be captured by gamma radiography of the areas taking up the radioactive iodine, and allows assessment of thyroid function. When coupled with other compounds, such as a monoclonal antibody, iodine I 123 can be used for tissue-specific radioimaging and therapy. ( NCI )] (UMLS (NCI) C0303023) =Pharmacologic Substance; Indicator, Reagent, or Diagnostic Aid; Element, Ion, or Isotope
|
- 43. 26i
- [Mandibular right lateral incisor implant ( HL7V3.0 )] (UMLS (HL7) C1552196) =Medical Device =Artificial dentition;
| - 93. I-124
- [A radioactive isotope of iodine, a nonmetallic element of the halogen group, with an atomic mass of 124 and a half-life of 4.18 days with radioimaging property. Selectively accumulating in thyroid glands, iodine I 124 releases, in addition to gamma rays, positrons that can be captured by positron emission tomography (PET) to allow assessment of thyroid function. When coupled with other compounds, such as a monoclonal antibody, iodine I 124 can be used for tissue-specific radioimaging and therapy. ( NCI )] (UMLS (NCI) C0303024) =Element, Ion, or Isotope
|
- 44. 27i
- [Mandibular right canine implant ( HL7V3.0 )] (UMLS (HL7) C1552197) =Medical Device =Artificial dentition;
| - 94. I-CORONARY
- [Intracoronary ( HL7V3.0 )] (UMLS (NCI) C0595454) =Functional Concept ;
=RouteBySite;
=Infusion, intracoronary;
Injection, intracoronary |
- 45. 28i
- [Mandibular right first premolar implant ( HL7V3.0 )] (UMLS (HL7) C1552198) =Medical Device =Artificial dentition;
| - 95. I-Kappa-B-Epsilon
- [Expressed in spleen, testis, lung, kidney, pancreas, heart, placenta, brain, granulocytes, and macrophages by human NFKBIE Gene (NFKBI), 361-aa 38-kDa cytoplasmic I-Kappa-B-Epsilon contains 6 ANK repeats and preferentially interacts with p65 RELA homodimers and with p65-cRel heterodimers. By complexing with and trapping NF-Kappa-B in the cytoplasm, NFKBIE inhibits and likely regulates NFKB. Serine phosphorylation of NFKBIE results in proteasome-dependent degradation. (NCI) ( NCI )] (UMLS (NCI) C1449065) IKBE;
IKB-Epsilon;
NF-Kappa B Inhibitor Epsilon;
NF-Kappa-B IE;
NFKBIE;
Nuclear Factor of Kappa Light Polypeptide Gene Enhancer in B-Cells Inhibitor Epsilon =Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 46. 29i
- [Mandibular right second premolar implant ( HL7V3.0 )] (UMLS (HL7) C1552199) =Medical Device =Artificial dentition;
| - 96. I01, I02, I03, I07
- (UMLS (HL7) C1549899) =Intellectual Product =Message structure;
|
- 47. 2i
- [Maxillary right second molar implant ( HL7V3.0 )] (UMLS (HL7) C1552166) =Medical Device =Artificial dentition;
| - 97. I01, I04
- (UMLS (HL7) C1549894) =Intellectual Product =Message structure;
|
- 48. 3-Isoxazolecarboxylic Acid, 5-methyl-, 2-(phenylmethyl)hydrazide
- [A hydralazine and monoamine oxidase (MAO) inhibitor with antidepressant activity. Isocarboxazid blocks the breakdown (oxidative deamination) of biogenic amines by inhibiting MAO, thereby increasing the concentrations of norepinephrine and 5-hydroxytrytamine (5-HT) at central aminergic receptors. These neurotransmitters are involved in sustaining mood and emotions. The down-regulation of central beta-adrenergic and serotonergic receptors by chronic inhibition of MAO may also contribute to the antidepressant effects seen by isocarboxazid. (NCI05) ( NCI )] (UMLS (NCI) C0022154) =Organic Chemical; Pharmacologic Substance ;
=isoxazole;
[CN602] MONOAMINE OXIDASE INHIBITOR ANTIDEPRESSANTS =ISOCARBOXAZID 10 MG;
| - 98. I02
- (UMLS (HL7) C1549895) =Intellectual Product =Message structure;
|
- 49. 30i
- [Mandibular right first molar implant ( HL7V3.0 )] (UMLS (HL7) C1552200) =Medical Device =Artificial dentition;
| - 99. I03
- (UMLS (HL7) C1549896) =Intellectual Product =Message structure;
|
- 50. 30id
- [Mandibular right first molar implant distal hemisection ( HL7V3.0 )] (UMLS (HL7) C1552202) =Medical Device =Artificial dentition;
| - 100. I04
- (UMLS (HL7) C1549900) =Intellectual Product =Message structure;
|
home
